Expert Review Of Neurotherapeutics

Expert Review Of Neurotherapeutics

神经治疗学专家评论

  • 2区 中科院分区
  • Q2 JCR分区

期刊简介

《Expert Review Of Neurotherapeutics》是由Taylor and Francis Ltd.出版社于2001年创办的英文国际期刊(ISSN: 1473-7175,E-ISSN: 1744-8360),该期刊长期致力于临床神经病学领域的创新研究,主要研究方向为CLINICAL NEUROLOGY-PHARMACOLOGY & PHARMACY。作为SCIE收录期刊(JCR分区 Q2,中科院 2区),本刊采用OA未开放获取模式(OA占比0.0111...%),以发表临床神经病学领域等方向的原创性研究为核心(研究类文章占比25.93%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在108篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Expert Review Of Neurotherapeutics审稿周期约为 。该刊近年未被列入国际预警名单,年发文量约108篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 108 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
CLINICAL NEUROLOGY 临床神经病学 PHARMACOLOGY & PHARMACY 药学
2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CLINICAL NEUROLOGY 临床神经病学 PHARMACOLOGY & PHARMACY 药学
3区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q2 73 / 277

73.8%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 105 / 354

70.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q3 162 / 278

41.91%

学科:PHARMACOLOGY & PHARMACY SCIE Q3 183 / 354

48.45%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7 SJR:0.957 SNIP:1.069
学科类别 分区 排名 百分位
大类:Medicine 小类:Neurology (clinical) Q1 82 / 400

79%

大类:Medicine 小类:Pharmacology (medical) Q1 56 / 272

79%

大类:Medicine 小类:General Neuroscience Q2 34 / 113

70%

期刊发文

  • Targeting adverse effects of antiseizure medication on offspring: current evidence and new strategies for safety

    Author: Sha, Leihao; Yong, Xihao; Shao, Zhenhua; Duan, Yifei; Hong, Qiulei; Zhang, Jifa; Zhang, Yunwu; Chen, Lei

    Journal: EXPERT REVIEW OF NEUROTHERAPEUTICS. 2023; Vol. 23, Issue 2, pp. 141-156. DOI: 10.1080/14737175.2023.2176751

  • Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis

    Author: Abdullahi, Auwal; Wong, Thomson W. L.; Van Criekinge, Tamaya; Ng, Shamay S. M.

    Journal: EXPERT REVIEW OF NEUROTHERAPEUTICS. 2023; Vol. 23, Issue 2, pp. 187-203. DOI: 10.1080/14737175.2023.2177154

  • Effect of antiplatelet pretreatment on safety and efficacy outcomes in acute ischemic stroke patients after intravenous thrombolysis: a systematic review and meta-analysis.

    Author: Sun C1,2, Song B1,2, Jiang C3, Zou JJ2.

    Journal: Expert Rev Neurother. 2019 Apr;19(4):349-358. doi: 10.1080/14737175.2019.1587295. Epub 2019 Mar 8.

  • Intravenous immunoglobulins for Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease: A systematic review with meta-analysis.

    Author: Liu J1, Wang LN2.

    Journal: Expert Rev Neurother. 2019 May 23:1-6. doi: 10.1080/14737175.2019.1620106. [Epub ahead of print]

  • Challenges in the treatment of Alzheimer's disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors.

    Author: Kuo YC1, Rajesh R1.

    Journal: Expert Rev Neurother. 2019 May 29:1-30. doi: 10.1080/14737175.2019.1621750. [Epub ahead of print]

  • Discriminating schizophrenia disease progression using a P50 sensory gating task with dense-array EEG, clinical assessments, and cognitive tests.

    Author: Luo Y1,2,3,4, Zhang J1,2,3,4, Wang C5, Zhao X1,2,3,4, Chang Q1, Wang H1,2,4, Wang C5.

    Journal: Expert Rev Neurother. 2019 May;19(5):459-470. doi: 10.1080/14737175.2019.1601558.

  • Prognostic implications of the Ankle Brachial Index in patients with acute ischemic stroke: A meta-analysis.

    Author: Hao Z, Yang C, Tao W, Liu M.

    Journal: Expert Rev Neurother. 2016;16(3):351-8. doi: 10.1586/14737175.2016.1142875. Epub 2016 Feb 8.

  • Post-epilepsy stroke: A review.

    Author: Jin J, Chen R, Xiao Z.

    Journal: Expert Rev Neurother. 2016;16(3):341-9. doi: 10.1586/14737175.2016.1151355.